
Neuro-Oncologist

No OPD information available
Brain Stem Cancer
Brain Tumor
Diffuse Midline Glioma H3 K27M-Mutant
Medulloblastoma
Pineoblastoma
Pineocytoma
Posterior Fossa Tumor
Astrocytoma
Atypical Teratoid Rhabdoid Tumor (ATRT)
Embryonal Tumor with Multilayered Rosettes
Ependymoma
Glioma
Gliomatosis Cerebri
Hearing Loss
Infantile Neutropenia
Rhabdoid Tumor
Teratoma of the Mediastinum
Tim Hassall is a male doctor who helps patients with different types of brain and spinal cord tumors. Some of the conditions he treats are Brain Stem Cancer, Brain Tumor, and Glioma. Tim also helps with hearing loss and other medical issues like Neutropenia.
Tim Hassall is very skilled at treating these conditions and uses special techniques to help patients feel better. He is very good at communicating with patients, which is why they trust him. Patients feel comfortable talking to Tim about their health concerns.
Tim Hassall stays updated with the latest medical knowledge and research to provide the best care for his patients. He works closely with other medical professionals to share information and improve patient outcomes.
Tim Hassall has made a positive impact on many patients' lives through his work. His research on treatments like Nivolumab and clinical trials like Repotrectinib show his dedication to finding new ways to help patients with brain tumors.
One of Tim Hassall's notable publications is about the safety and effectiveness of a treatment for pediatric patients with high-grade CNS malignancies. He is also involved in a clinical trial studying the effects of a new treatment on pediatric patients with advanced or metastatic malignancies.
Overall, Tim Hassall is a caring and knowledgeable doctor who works hard to improve the lives of his patients with brain and spinal cord tumors. His dedication to research and collaboration with other medical professionals make him a trusted healthcare provider in his field.
Enrollment Status: Recruiting
Published: February 14, 2025
Intervention Type: Drug
Study Drug: Oral Repotrectinib (TPX-0005)
Study Phase: Phase 1/Phase 2
